Exocrine secretions in the digestive tract of domestic livestock are controlled by a combination of neural and endocrine inputs. The parasympathetic domain of the autonomic nervous system is responsible for efferent signals that regulate most exocrine secretory processes. Exocrine tissues possess cholinergic muscarinic receptor subtypes that are different from those found in brain, heart and muscle tissues. Cholinergic stimulation of specific muscarinic receptor subtypes has enhanced secretions of the salivary glands and pancreas. These changes in output of exocrine glands can alter digestive function that may benefit production of cattle and swine. 
proportions and quantities of VFA produced in the rumen (Harrison et al., 1975; Isaacson et al., 1975; Cole et al., 1976; Rode et al., 1985; Owens and Goetsch, 1986) . Any or all of these changes resulting from increased stimulation of salivary flow or motility could improve efficiency of utilization of nutrients by the animal.
Insufficient release or activity of pancreatic or intestinal enzymes has been implicated in a number of malabsorption and feed utilization problems in domestic livestock, including starch digestion in cattle and postweaning check syndrome in piglets (Pehrson et al., 1981; Owsley et al., 1986) . The cause of these problems, however, is far from certain. For cattle fed highconcentrate diets, the involvement of exocrine secretions has been the subject of vigorous scientific debate (Pehrson et al., 1981; phskov, 1986; . Increasing the quantity of enzymes released from the pancreas as well as the volume of pancreatic fluid should increase the amount and total activity of pancreatic enzymes in intestinal digesta. If enzyme supply limits digestion, an increase in enzyme supply will increase nutrient digestion in the lower gastrointestinal tract and thereby improve efficiency.
The value of stimulating exocrine secretions in livestock as a means of promoting digestive function and feed efficiency is dependent on the identification of a method of stimulating digestive secretions in a predictable and specific fashion. Stimulation of exocrine s e a etory function is controlled by elements of both the neural (parasympathetic) and endocrine systems (Case, 1987) . Recent developments in our understanding of the basis of specificity of parasympathetic control of various tissue functions has allowed new approaches to selective control of exocrine secretions to be explored.
Cholinergic Regulation of the Gastrointestinal Tract
Efferent parasympathetic stimuli to the digestive tract and accessory organs are provided to the salivary glands and the esophagus via the facial, glossopharyngeal and cranial nerves and to the rumen, stomach, intestines, pancreas and gall bladder via the vagal neme (Frandson, 1974; Sellers, 1977) . The neurons in this portion of the autonomic nervous system are characterized by long myelinated pre-ganglionic fibers and short post-ganglionic processes that are not myelinated (Robertshaw and Tietz, 1984) . Nerve impulses stimulate effector organs (i.e., glands, smooth muscle) by the release of the neurotransmitter, acetylcholine at the neuronal synapse. Some peptidergic transmitters (m-transmitters) also may be located within and released by the same synaptic terminal (Bradford, 1986; Ekstrom 1987) . Indeed, in some tissues, such as the salivary gland, acetylcholine and its peptidergic co-transmitters can be preferentially released depending on the frequency of the nerve impulse (Edwards, 1986; Ekstrom, 1987) . The acetylcholine released then binds to receptors on the effector organ and stimulates metabolic processes unique to that tissue (Baum, 1987) .
A question that has puzzled neurobiologists is how a ubiquitous neurotransmitter like acetylcholine can modulate so many divergent physiological effects simultaneously. Classically, it was believed that the parasympathetic nervous system contained two basic receptor groups for acetylcholine, nicotinic (because they are stimulated by the plant alkaloid nicotine), located on the nerve ganglia and motor junctions, and muscarinic (stimulated by the alkaloid, muscarine, found in the fly agaric mushroom), located on effecter organs and ganglia (Robertshaw and Tietz, 1984) . Only recently, with the development of selective cholinergic agonists and antagonists such as piremepine, have we realized that there are subtypes of muscarinic receptors that may mediate selective physiological processes in different tissues (Hammer and Giachetti, 1982; Birdsall et al., 1984) . Hammer and Giachetti (1982) identified two different populations of muscarinic receptors based on their relative affiinities for the selective antagonist, piremepine. The highaffinity receptors, termed M1, are found primarily in the corpus striatum, cerebral cortex and hippocampus regions of the brain as well as in peripheral ganglia (Hammer and Giachetti, 1982; Watson et al., 1983) . The lowaffinity receptors, termed h42, are found in cardiac tissue and elements of the gastrointestinal tract such as smooth muscle and exocrine glands, as well as in the urinary bladder (Hammer and Giachetti, 1982; Vickroy et al., 1984) . Additionally, radioligand binding studies, with novel antagonists such as AFDX116, suggest that high-and low-affinity 3025 subtypes of M 2 receptors exist. These have been variously described as M2a (cardiac) and M 2 p or M3 (glandular) receptors (Ladinsky et al., 1987 (Ladinsky et al., , 1988 . Probably there are other muscarinic subtypes, because four muscarinic receptor subtypes have been cloned from human tissue (PeraIta et al.. 1988) . The structural basis for the biochemical specificity of each of these receptors is not clear. AU subtypes possess an extracellular, glycosylated amino t d a l end that folds back into the cell membrane via seven transmembrane segments. Aspartate residues in transmembrane segments two and three are highly conserved across all subtypes and likely are involved in the binding of acetylcholine and other agonists (Peralta et al., 1988; Wheatley et al., 1988) . Biochemical specificity may be dictated by the manner in which the intracellular peptide loop between transmembrane segments five and six interact with the G proteins (Peralta et al., 1988) .
Manipulation of Digestion through Administration of Parasympathomimetics
Parasympathomimetic secretagogues are substances that mimic acetycholine's stimulation of glandular secretion by directly binding to muscarinic receptors (Taylor, 1980) . A number of these substances, such as carbachol and pilocarpine, have been used experimentally both in vivo and in vitro to stimulate secretions from exocrine tissues of domestic livestock and laboratory species ( Sinha et al., 1974; Steer and Glazer, 1976; Werlin and Grand, 1979; Gumsey et al., 1980) . Unfortunately, these compounds do not have complete specificity for one particular subtype of muscarinic receptor (Vickroy et al., 1984) . During the 1960s and 1970s a parasympathomimetic, slaffamine (l-acetoxy-6-aminooctahydroindolizine), was isolated from Rhizocronia legurnincola Gough and Elliot, a fungal pathogen of red clover hay and other legumes (see review by Hagler and Croom, 1989) . Aust (1969 Aust ( , 1970 first described slaframine's (SF) high affiity for tissues of the gastrointestinal tract and accessory glands. More recently, we have determined that administration of purified SF to domestic ruminants results in beneficial alterations in digestive function (Croom and Hagler, 1987b) . It also has increased circulating levels of growth hormone in the chick, steer and pig Froetschel et al., 1987c; Hagler and Croom, 1989) .
Administration of SF in doses ranging from 12 to 24 p e g BW resulted in sustained 30 to 79% increases in resting salivary flow in steers consuming a high-grain diet (Froetschel et al.. 1986b Figure 1) . Furthermore, administration of SF over 24 h increased flow of liquid digesta from the rumen and the molar ratio of acetate to propionate (Froetschel et al., 1987a; Jacques et al., 1989) . Administration of 10 to 20 pg SFkg BW twice daily i.m. to steers fed a 60% concentrate-40% wheat silage diet in 12 equal portions daily for 18 d increased total abomasal flow of liquid digesta (Table 1; Froetschel et al., 1989a) , even though fractional ruminal liquid turnover rate and ruminal volume were not affected. Preliminary data suggest that when SF was administered at 10 to 30 p e g BW once a day to steers fed a similar diet twice daily for 14 d, ruminal volume and DM turnover rate increased (Table  1; Froetschel et al., 1989b) .
Despite inherent difficulties in their use, other cholinergics have been found to alter the physical environment of the rumen. Wiedmeier et al. (198%) demonstrated that oral administration of the parasympathomimetic pilocarpine at 2 to 4 r n e g BW to dry cows fed a 45% concentrate diet over a 22d period increased ruminal pH, liquid dilution rate and rate of particulate passage (Table 1 ). Further studies indicated that similar changes in the ruminal environment could be achieved with both pilocarpine and carbachol when administered via S.C. implants to cows fed a 50% concentrate diet (Table 1; Wiedmeier et al., 1987a) .
The increased flow of ruminal liquid and particulate digesta noted with administration of cholinergics was due largely to increased salivary flow into the rumen. Saliva represents 70% of the total water input into the rumen (Poutianen, 1968) . Large increases in saliva flow should stimulate passage of digesta out of the rumen. The effects of motility changes on the response to these compounds is less clear. Froetschel et al. (1986a) Froetschel, unpublished data) . Wiedmeier et al. (1987a) noted that both pilocarpine and carbachol have been reported to stimulate motility; this may account, in part, for changes in digesta flow associated with the administration of these drugs. Perhaps cholinergic drugs exert these effects by stimulation of the reticulo-omasal orifice. Ruckebusch (1983) noted that the cholinergic receptors of the reticulo-rumen are muscarinic. Vagal stimulation causes a relaxation of the reticulo-omasal sphincter (Newhook and Titchen, 1972) , although the mechanism is not blocked by atropine. Perhaps administration of cholinergics causes relaxation of the reticulo-omasal sphincter and allows less res-. tricted passage of the ruminal digesta to the lower digestive tract (Froetschel et al., 1986b) . The administration of cholinergics to ruminants consuming high-grain, low-fiber diets generally results in alterations of ruminal fermentation expected with increased ruminal buffering and digesta flow (Table 2) . In cows fed a 45% concentrate diet twice daily supplementation with pilocarpine at 1 to 4 mgekg BW-l-d-' increased ruminal VFA concentrations 4 to 27%; VFA flow from the m e n increased 35 to 46% (data not shown) and ruminal N H 3 N concentration decreased (Wiedmeier et al., 1987b) . No changes in molar percentage of VFA or in the acetate to propionate ratio were noted in this study; however, there were trends (P < .22) for increases in both bacterial cell mass and efficiency of bacterial mass production (Table  3) . In a later study with cows fed a 50% concentrate diet twice daily, pilocarpine or carbachol administered via S.C. implants in- creased the ruminal molar ratio of acetate to propionate (Table 2 ; Wiedmeier et al., 1987a) as well as the percentage of cellulolytic bacteria in the rumen. Nonsignificant trends for increased ruminal bacterial mass and a decreased ruminal ammonia pool also were reported (Wiedmeier et al., 1987a) . Froetschel et al. (1989a) reported that efficiency of ruminal microbial protein production increased in steers fed a 60% concentrate diet 12 times daily when SF was injected at 10 to 20 pgkg BW twice daily (Table 3 ). The treatment had no effect on the concentration of major ruminal bacterial end-products (Table 2 ). This may have been due to the attenuating effects of frequent feeding on ruminal fermentation %MF = OM truly fermented. dLinear effect due to treatment (P < .lo). (Froetschel et al., 1989a) ; however, when SF was administered to cows fed once daily, no effect on the molar percentages of ruminal VFA was noted (data not shown; Froetschel et al., 1989b) . The effects of cholinergics on nutrient digestibility by ruminants have been studied. Wiedmeier et al. (1987b) investigated the effects of orally administered pilocarpine once daily at 1 to 4 mg/kg BW on total tract digestibility of nutrients in dry cows (Table 4) . They reported that digestibilities of DM, CP and cellulose were increased with the 2 and 4 m@g BW dosage of pilocarpine. Similar trends were noted when pilocarpine and carbachol were administered via S.C. implant (Wiedmeier et al., 1987a) . The authors attributed most of the changes in digestibility to increased ruminal digestion associated with an enhanced salivary flow and digesta buffering. However, enhanced pancreatic function cannot be entirely ruled out because pilocarpine stimulates pancreatic secretions (NevaIainen, 1970) . Steers fed a 60% concentrate diet and administered 10 to 20 pg SF/kg BW every 12 h for 18 d had decreased ruminal DM, ADF and CP digestibilities, whereas postruminal digestibility of these nutrients and starch increased dramatically (Table 4) . There was no change in total tract digestibility of any nutrient except starch, which increased from 93 to 98% (Froetschel et al., 1989a) . Presumably, the increased nutrient digestibility in the lower gastrointestinal tract was due to increased hydrolytic digestion in the intestines or increased cecal fermentation. Slaframine has been reported to increase pancreatic fluid volume and lipase, amylase, trypsin and chymotrypsin activity in the sheep, calf and goat (Figure 2 ; Aust, 1969 Aust, , 1970 .
There have been few studies investigating the effects of cholinergics on animal production. Gaskins et al., (1989) account for the decreased performance reported by Gaskins et al. (1989) . Slaframinetreated animals had consistently higher blood glucose and nonesterified fatty acids and lower plasma urea N concentrations (Gaskins, 1986 ). These differences in metabolite concentrations may be the result of somatotrophin release induced by SF . To date, there have been no studies reported in which cattle were administered cholinergics during long-term production studies. Further research needs to be conducted to determine whether the alterations in digestive function achieved through the administration of cholinergics translates into enhanced feed efficiency under practical production conditions. Few studies have described the effects of administration of cholinergics in nonruminant livestock, although some compounds, such as carbachol, have been used to stimulate exocrine secretions in vivo and in vitro in laboratory animals. Froetschel et al. (198%) reported that administration of low levels of SF for the first 21 d of life of chicks caused no changes in growth or feed efficiency. Digesta lipase and trypsin activities decreased, whereas the protein content of digesta increased Croom et al. (1989) increased intestinal trypsin by 1,200% and chymotrypsin by 30% in 14-d-old piglets administered 1 mg pilocarpinekg BW every 8 h for 7 d (Table 5 ). There were no significant differences in intestinal or pancreatic lipase or amylase as well as BW and gain between control (saiine-injected) and treated piglets. Owsley et al. (1986) suggested that lack of ability of weanling pigs to release digestive enzymes from the pancreas in response to secretory stimuli may explain, in part, the phenomenon of the postweaning check syndrome. Administration of cholinergics needs to be investigated as a method of overcoming this production problem.
lrnpllcations Recent advances in our understanding of neural control of gastrointestinal processes, including exocrine secretion, suggest that receptor populations of muscarinic receptors regulate digestion. Parasympathomimetic drugs with a high degree of affinity for the gastrointestinal tract may be useful to manipulate digestion in production situations such as the feeding of high-grain, restricted roughage diets to cattle. By virtue of their ability to enhance salivation, such drugs also may help to extend scarce forage supplies in times of drought. Additionally, cholinergic stimulation also may benefit noiruminant production ment of the exocrine function
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